Adalimumab therapy for recalcitrant pyoderma gangrenosum.
about
Biological therapy for dermatological manifestations of inflammatory bowel diseaseUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.Adalimumab in dermatologyCoexistence of pyoderma gangrenosum and sweet's syndrome in a patient with ulcerative colitisThe role of cytokines in the pathomechanism of cutaneous disordersExtraintestinal Manifestations of Inflammatory Bowel Disease.
P2860
Q35058744-577812C3-8017-4FC1-85D6-A9DDF263063AQ36171750-8AC6EBC8-8CC1-4FE3-8318-384B3D12B940Q36202770-03B88177-0FEE-48BD-812A-5F611E82C93DQ37142425-4DB87E3E-986C-4B06-800C-5ABEB3AFC607Q38968619-2D7894B5-D124-4C10-A430-FB3F757CEFEEQ42167700-EA21ADBE-7727-4A38-AC9D-B3670509F572Q55206226-B0B18D9F-E50D-40BB-BC53-A2C92E633C13
P2860
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@ast
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@en
type
label
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@ast
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@en
prefLabel
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@ast
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@en
P2093
P2860
P1433
P1476
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
@en
P2093
Benjamin D Ehst
Deborah L Cummins
Grant J Anhalt
Jon H Meyerle
Margaret A Fonder
P2860
P577
2006-11-20T00:00:00Z